dsm-firmenich, innovators in nutrition, health, and beauty, confirms that shareholders elected Richard Ridinger as Chairman of the Board of Directors.

Richard Ridinger succeeds Thomas Leysen, who has retired from the Board. Thomas played a pivotal role in shaping the company’s strategic direction and establishing a strong foundation for its next phase of growth and value creation.

Ridinger has served as an independent member of the Board of Directors of dsm-firmenich since 2023 and, in addition to his role as Chairman, has also been elected as a member of the Compensation Committee.

He brings extensive executive and board-level experience across Pharma, Home & Personal Care, and Nutrition & Health, as well as a deep understanding of the company, its strategy and stakeholders.